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AbstrAct
background The key role played by research nurses 
in coordinating clinical trials in a paediatric setting has 
developed in line with increasing complexities of trial 
design. A questionnaire-based survey was conducted to 
investigate the training of research nurses involved in 
paediatric trials across Europe, to identify potential training 
needs and compare roles across specialties and countries.
Methods A structured, cross-sectional questionnaire 
survey was used, with the aim of describing and 
quantifying research nurse experiences. The questionnaire 
was designed to cover four main areas of interest: 
demographics, training, clinical trial experience and 
research nurse roles/activities.
results The questionnaire was completed by 341 
respondents across 45 different specialties in 20 European 
countries. A higher percentage of research nurses within 
3 years of taking up post were dissatisfied with the level 
of training received (16%), as compared with those in 
post for 3–6 years (8%) and >6 years (6%). There was 
a trend towards a higher percentage of respondents 
receiving self-funded training in mainland Europe, with 
reported values of 15%–20%, as compared with <5% in 
the UK and Ireland. Only 3% of research nurses prescribed 
investigational medicinal products in a clinical trial setting, 
with contrasting roles observed between countries.
conclusions While high levels of training satisfaction 
were observed, 67% of respondents felt they would benefit 
from additional training in line with frequently changing 
practices. Currently, low levels of nurse prescribing are 
observed in a paediatric clinical trial setting across Europe. 
Appropriate research nurse training programmes should be 
promoted through national networks across Europe.
IntroductIon
There is a clear need to accelerate the devel-
opment of drugs across a wide range of child-
hood disease specialties.1 In order for this to 
be achieved, high-quality ethical research on 
the safety and efficacy of medicines in chil-
dren is needed. In this respect, the research 
nurse plays an increasingly pivotal role in 
the successful conduct of paediatric clinical 
trials.2
Clinical trials in children have an inherent 
default level of complexity relating to regula-
tory, methodological, ethical and administra-
tive issues, with additional burdens commonly 
introduced for multinational studies.3 The 
role of the research nurse has developed in 
line with increasing numbers of often compli-
cated research studies commonly built into 
trial design, to generate as much information 
What this study hopes to add?
 ► Approximately two-thirds of research nurses felt 
that they would benefit from additional training in 
specific areas, with a clear relationship observed 
between length of time in post and level of training 
satisfaction.
 ► An increased level of nurse prescribing may be 
beneficial in paediatric specialties, with only 3% of 
participants prescribed investigational medicinal 
products in a clinical trial setting.
 ► Sharing of the information generated through 
national research nurse networks should be used to 
encourage the development of paediatric research 
nurse training programmes.
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What is already known on this topic?
 ► Research nurses are increasingly involved in all 
stages of the development of complex clinical trials 
conducted across paediatric specialties.
 ► It is important that research nurses are 
appropriately trained for the various regulatory, 
methodological, ethical and administrative aspects 
of clinical trial design.
 ► Few studies have been published focusing on 
the level of training and roles played by research 
nurses working in paediatric specialties across 
Europe.
group.bmj.com on September 26, 2017 - Published by http://bmjpaedsopen.bmj.com/Downloaded from 
2 Veal GJ, et al. BMJ Paediatrics Open 2017;1:e000170. doi:10.1136/bmjpo-2017-000170
Open Access
Box 1 summary of questions in final questionnaire 
(response required and follow-up questions)
 ► Across what specialties do you work in paediatrics? (select all that 
apply; if ‘other’, please provide details)
 ► What age of children do you work with? (select all that apply)
 ► How long have you worked as a research nurse?
 ► How many phase I, II, III or IV clinical trials have you participated 
in?
 ► Do you feel that you have received appropriate training for the 
role(s) you carry out in your position?
 ► Do you feel that you would benefit from additional training in some 
aspects of your job? (if ‘yes’, please comment)
 ► How would you best describe describe the training that you 
received for your role? (select one)
 ► If you have received Good Clinical Practice (GCP) training, has this 
been generic GCP training or paediatric-specific GCP training?
 ► If you have received additional training, please provide further 
information with regards to the type of training.
 ► How frequently do you receive training in your current job?
 ► How frequently do you receive GCP certified training within your 
role?
 ► How would you best describe the training that you received when 
you first started in post? (select all that apply)
 ► How would you best describe the training updates that you 
receive? (select all that apply)
 ► Which of the following activities do you have experience of actively 
participating in?
 ► Within your role, do you participate in CTIMP (Clinical Trial of an 
Investigational Medicinal Product) studies?
 ► If ‘yes’, which of the following roles do you perform?
 ► If ‘yes’ to any of the above, have you received specific training for 
this?
 ► Are you involved in the following types of paediatric clinical trials? 
(tick all that apply)
as possible relating to the new treatment. Outside of the 
collection of blood samples for routine clinical analysis, 
samples are frequently requested for a range of substudies 
including clinical pharmacology and biomarker studies, 
pharmacogenomics, biobanking and cytogenetics.4 Clin-
ical samples will commonly be requested at multiple 
time points and require the collection and recording of 
data and completion of clinical trial visit-associated case 
report forms (CRFs), often via trial-specific electronic 
data capture (EDC) systems. These studies are carried 
out alongside more routine research nurse responsibil-
ities, including day-to-day study management, patient 
screening, provision of patient information sheets, 
appropriate collection of consent/assent and collab-
oration with other members of the multidisciplinary 
team required to ensure a positive experience for study 
patients.5
The European Network of Paediatric Research at the 
European Medicines Agency (Enpr-EMA) consists of 
a consortium of research networks, investigators and 
centres with expertise in performing clinical trials in chil-
dren and adolescents.6 A working group was established 
by Enpr-EMA to investigate potential needs and gaps in 
research nurse training across specialties and countries. 
A questionnaire-based survey was carefully planned to 
compare experiences and seek the views of research 
nurses working in paediatric settings across Europe, in 
addition to generating information on the extent of 
involvement in clinical trial activities and the specific 
roles carried out by research nurses in different countries 
and specialties. Such an approach may allow the identifi-
cation of potentially desirable training models for recom-
mendation by Enpr-EMA at a European level.
MAterIAls And Methods
Questionnaire design and preparation
A structured, cross-sectional questionnaire survey, 
informed by previous research on nurse training and 
questionnaire development,7–9 was designed to cover 
four main areas of interest. The first section covered basic 
demographic information, including disease specialties, 
age of children being cared for and length of time as a 
research nurse. The second section focused on the level, 
frequency and method of training received. The third 
area focused on clinical trials experience with regards 
to involvement in different types of trials and various 
aspects of developing and running studies. Finally, paedi-
atric research nurse roles and activities were investigated, 
from patient consent, prescribing and administration of 
investigational medicinal products (IMPs), through to 
sample collection, processing and transport.
The design incorporated fixed choice and open-ended 
questions and was piloted on an initial cohort of 20 paedi-
atric research nurses to check for usability. Following 
minor alterations and additions to the questionnaire at 
this point, a final version was approved for dissemination. 
box 1 summarises the questions incorporated in the final 
questionnaire and the full questionnaire is provided as 
an online supplementary figure 1.
Participants and data collection
The final questionnaire was made available via an elec-
tronic link through the internet-based survey tool 
provider Google Forms. National and disease specialty 
networks of paediatric research nurses were identified 
through Enpr-EMA networks and the identification of 
appropriate European groups through internet searches. 
A link to the Google Forms questionnaire was sent to 
lead network contacts alongside a letter from Enpr-EMA, 
explaining the purpose and aims of the survey, for dissem-
ination to research nurses within individual networks or 
groups. The questionnaire was translated into French 
and Spanish as requested by specific networks and was 
made available for a 9 month period between April and 
December, 2016.
data analysis and statistical analysis
Data entry and initial analysis were carried out using 
Microsoft Excel 2013 and Qlik Sense V.3.1 (Qlik Interna-
tional AB). Statistical analysis was carried out using the χ2 
test as appropriate using SPSS statistical software.
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Table 1 Demographics of research nurse respondents
Characteristic
No. of 
respondents %
Evaluable responses 341
Age of patients cared for (years)
  <1 284 83
  1–3 278 82
  4–10 295 87
  11–16 287 84
  >16 234 69
Length of time working as a research 
nurse (years)
  <3 106 31
  3–5 90 26
  6–10 81 24
  >10 48 14
  Unknown 16 4.7
Country
  UK 189 55
  France 22 6.5
  Germany 16 4.7
  Norway 16 4.7
  Spain 15 4.4
  Ireland 14 4.1
  Switzerland 13 3.8
  Netherlands 11 3.2
  Denmark 10 2.9
  Austria 8 2.3
  Finland 7 2.0
  Belgium 6 1.7
  Sweden 4 1.2
  Portugal 3 0.9
  Other* 7 2.3
Number of specialties
  1 116 34
  2 73 21
  3–4 46 13
  5–9 84 25
  10–14 18 5.3
  15–20 4 1.2
*Country grouping ‘other’ includes Italy (2), Greece (2), Hungary (1), 
Luxembourg (1) and Turkey (1).
results
demographics of respondents
The questionnaire was completed by 341 research nurses 
from 20 European countries. The respondents worked 
across 45 different disease specialties, with 34% working 
with children in a single specialty, 21% in two specialties, 
14% across three or four specialties and the remaining 
respondents (31%) working across at least five specialties. 
The most common specialty areas were respiratory 
diseases, oncology and diabetes. Respondents spanned a 
wide range of experience levels, with approximately 1/3 
of participants (31%) having worked as research nurses 
for <3 years and 38% having >6 years of experience. 
Table 1 provides a summary of the demographics of the 
research nurses who participated in the study.
training received and satisfaction with level of training
Data collected on frequency of training suggested that 
research nurses received regular training, with 53% 
receiving formal training at 6 monthly, annual or 2 yearly 
intervals, and 38% being trained ‘as needed’. Less than 
10% of respondents received training at intervals of >2 
years.
A total of 147 research nurses (43%) were fully satisfied 
with the level of training received, with 32 (9%) respon-
dents not satisfied and a further 145 (43%) satisfied that 
they were appropriately trained for the majority of tasks 
that they carried out; the remaining 17 (5%) partic-
ipants failed to respond to this question. Further anal-
ysis suggested that a significantly higher percentage of 
research nurses within the first 3 years of taking up their 
post were dissatisfied with their level of training (16%) 
as compared with those with 3–6 years (8%) and >6 years 
(6%) of experience (p<0.001). Overall, there was a clear 
trend towards a relationship between length of time 
in post and level of training satisfaction (see figure 1). 
Looking at the results obtained geographically, for those 
countries with at least 10 respondents, higher percent-
ages of nurses dissatisfied with the level of training 
received were observed in Norway (25%) and Denmark 
(20%). In contrast, 100% of respondents from Spain 
and the Netherlands were either fully satisfied or satis-
fied with the level of training received for the majority of 
tasks carried out. In response to the direct question as to 
whether they would benefit from extra training in some 
aspects of their job, 67% of all respondents indicated that 
this would be beneficial.
With regards to the type of training received, in terms 
of whether this was carried out online or in person, organ-
ised internally or run by an external organisation, institu-
tion or self-funded, there were no clear trends observed in 
terms of the level of training satisfaction (p>0.05). Simi-
larly, there was no relationship between the frequency of 
training received and the level of satisfaction reported 
(p>0.05). Interestingly, 68% of research nurses received 
training updates online and this value was also high (54%) 
in terms of the initial method of training received when first 
in post. While there were no particularly striking findings 
observed when these data were analysed by country, there 
appeared to be a higher percentage of respondents who 
received self-funded training in mainland Europe, with 
reported values of 15%–20% in Germany, Norway, Swit-
zerland, Denmark and the Netherlands, as compared 
with <1% in the UK and <4% in Ireland.
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Figure 1 Level of satisfaction with training received by level of experience in terms of length of time in research nurse post.
Specific questions were included in the questionnaire 
relating to the provision of Good Clinical Practice (GCP) 
training, with overall 96.5% (329/341) of research nurses 
having received GCP training, with 40% of these respon-
dents (132/329) having received paediatric-specific GCP 
training and 60% (197/329) generic GCP training. These 
figures were comparable across specialties and countries.
Additional training needs
Information relating to areas of additional training that 
research nurses would benefit from could be categorised 
into the following general areas of training: regulatory 
issues (21% of respondents who indicated that additional 
training would be beneficial), clinical trial coordination/
GCP-related (20%), nursing procedures (19%), infor-
mation technology (IT) based (10%), data analysis (8%) 
and communications skills training (6%). In the area of 
clinical trials in particular, a wide range of training needs 
were identified including areas such as research govern-
ance, trial set-up, design and coordination, costing and 
finance. Similarly, requests for training in a wide range 
of nursing procedures and laboratory skills highlight the 
increasing requirement for research nurses to possess a 
wide range of skill sets consummate with complex clinical 
trial designs.
clinical trial experience
The questionnaire explored the role of the research nurse 
in various aspects of developing and running paediatric 
clinical trials. Approximately 1/3 of respondents (36%) 
were involved in the development of consent forms, 27% 
had experience of trial submission and 32% in the devel-
opment of trial CRFs. Approximately half of participants 
(46%) had experience of developing patient information 
sheets. These data were consistent across countries and 
specialties.
research nurse roles and activities
In terms of the activities in which participants are 
commonly involved, over 70% of research nurses actively 
participated in the collection and processing of blood 
samples (252 respondents) and the shipment/transport 
of clinical samples (242 respondents), with approxi-
mately 60% of respondents involved in the training and 
education of patients in terms of the administration of 
new medicines or procedures (207 respondents), and 
the administration of IMPs (205 respondents). Approx-
imately 1/3 of research nurses who responded to the 
survey were involved in taking consent and/or assent 
from patients (126 respondents) and only 3% (11 
respondents) prescribed IMPs in a clinical trial setting 
(see figure 2).
Further analysis of these data by country identified wide 
ranges in percentages of research nurses actively involved 
in the defined roles and activities described above. While 
percentages were high across all countries for routine 
roles such as the collection, processing and transport 
of clinical samples, marked differences were seen in the 
percentage of respondents taking patient consent for 
clinical trial participation. For those countries with at 
least 10 respondents, less than 10% of research nurses 
in Germany and Spain took consent, whereas approx-
imately half of UK research nurses (49%) and 80% of 
respondents from the Netherlands carried out this role. 
Percentages of research nurses who administered IMPs 
ranged from 15% in Switzerland to 87% in Spain, with 
small numbers of respondents (≤10%) responsible for 
prescribing IMPs in all countries except for Norway 
(13%) and Switzerland (23%). In terms of analysis of 
research nurse roles and activities by specialty area, there 
were no clear trends or differences observed.
dIscussIon
The current study was carried out to gather infor-
mation relating to the training and roles of research 
nurses who conduct paediatric clinical trials across 
Europe. A questionnaire-based survey was proposed and 
executed by Enpr-EMA, with responses gathered from 
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Figure 2 Summary of activities carried out by research nurses working in a paediatric setting. IMPs, investigational medicinal 
products.
341 respondents, encompassing 45 different disease 
specialties and 20 European countries. As there was no 
explicit sampling frame, in terms of a defined list of 
numbers of research nurses in the networks and centres 
who received the questionnaire to complete, it was not 
possible to address the extent of non-response bias 
and this represents an accepted limitation of the study. 
Similarly, while national and disease specialty networks 
of paediatric research nurses were identified through 
Enpr-EMA networks and the identification of appro-
priate European groups through internet searches, many 
lead network contacts were not research nurses and 
wider circulation of the study information and link to the 
survey may not always have been prioritised.
Results generated from the questionnaire were gener-
ally encouraging, with 86% of respondents either fully 
satisfied with the level of training received, or satisfied 
that they were appropriately trained for the majority of 
tasks that they carried out. Indeed, a healthy percentage 
of respondents had either completed formal postbach-
elor education or training programmes or obtained 
more focused training in key areas, commonly provided 
by sponsors or pharmaceutical companies. However, 
67% of respondents also felt that they would benefit 
from additional training, with a wide range of areas high-
lighted where training would be most beneficial. The 
most common areas for additional training reflected the 
increased complexities of modern day clinical trials and 
increasing requirement for research nurses to possess a 
wide range of skill sets.2 3 These included clinical trial 
set-up and management, IT skills, pharmacovigilance, 
CRF data entry and laboratory skills training. A number 
of respondents highlighted the challenges of keeping up 
to date with frequent changes to clinical trial practices 
relating to ever increasing GCP regulations.
In terms of how research nurses obtain training, 54% 
of respondents received their initial training online, 
when they first took up post, and 68% received training 
updates online. These figures highlight marked increases 
in online nurse training observed over the past 20 years, 
largely due to its convenience and flexibility. Online 
training can help to avoid problems relating to inten-
sive workloads and working shifts, which could provide 
barriers to research nurses attending scheduled training 
sessions. In this respect, many studies have reported posi-
tive outcomes from online nurse training, with learning 
outcomes comparable or even improved as compared 
with face-to-face training events.8
One interesting point raised by several participants, 
related to the expectation that they would gain relevant 
experience through ‘on the job’ training. This theory 
appears to be supported by the findings of the current 
study, with a clear relationship observed between length 
of time in post and level of training satisfaction reported. 
Several respondents highlighted the fact that they would 
have benefited from more training when they first started 
in post, at which time they were unaware of the training 
opportunities available. This may be particularly relevant 
to countries where higher levels of dissatisfaction were 
reported in terms of training received. For example, in 
some Nordic countries, more accessible research nurse 
training programmes have only relatively recently been 
developed, following studies highlighting a need for more 
relevant training to be made available.10 11 This represents 
an area that could be improved, through advertising 
and promotion of research nurse training events. The 
availability of induction packs for new research nurses, 
containing relevant information and useful links to 
networks where training is available, is commonplace in 
some countries and should be encouraged more widely. It 
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is accepted that the role of the research nurse may differ 
significantly between countries and that the current 
survey, while relatively expansive in terms of the number 
of respondents and countries involved, did not include 
respondents from many other European countries.
Data generated from the current study highlight the 
integral role that research nurses play in the running of 
clinical trials in paediatric specialties,2 3 with significant 
numbers of participants being involved in various wide-
ranging tasks. In terms of the practicalities of working in 
a clinical trial setting, high percentages of respondents 
were involved in taking patient consent, collection and 
processing of samples, patient training and the admin-
istration of IMPs. Despite relatively small numbers of 
respondents from individual countries, apparent differ-
ences were observed in the level of involvement in activi-
ties including administration of IMPs and taking consent. 
Such differences may reflect guidelines and philosophies 
within countries, with the role of taking consent being 
actively encouraged in the UK, but not being seen as an 
appropriate research nurse role in some European coun-
tries. Indeed, it is entirely feasible that while research 
nurses may feel comfortable in explaining clinical trials 
to patients and families, they may be less amenable to 
being responsible for the signing of consent forms. In 
this respect, it is important to understand that the appro-
priateness of research nurses taking on this responsibility 
may be related to the complexity of the particular clinical 
trial and the IMP involved. For research nurses working 
in environments where roles such as the taking of consent 
are encouraged, competency tools are commonly avail-
able to promote patient safety and may be included in 
research nurse induction packs referred to above.12
A key role absent from the activities of the vast majority 
of respondents related to the prescribing of IMPs, with 
only 3% of research nurses performing this role. For 
research nurses to prescribe medicines, including unli-
censed and clinical trial drugs, they are required to have 
the appropriate qualifications.13 In the UK, registered 
nurses with a minimum of 3 years of clinical experience 
must undertake a recognised ‘Nursing and Midwife 
Council’ accredited prescribing course through a UK 
university. Other countries have their own research nurse 
qualifications, which may contrast in terms of the level of 
training involved and the prescribing responsibilities of 
the research nurse.14 15
While nurse prescribing in the UK and Europe has 
developed significantly over the past decade, with an esti-
mated 19 000 nurse prescribers registered in the UK in 
2014,16 this remains a remarkably underdeveloped area. 
Indeed, experience in the UK indicates that differences 
exist between individual centres and health authorities, 
in terms of whether or not research nurses are able to 
prescribe IMPs, even if the appropriate level of training is 
in place. Therefore, the reported low numbers of research 
nurses responsible for prescribing IMPs may reflect local 
legislation, as opposed to a lack of desire for nurses 
to be involved in this area. Benefits of research nurse 
prescribing in the UK have been widely reported,17 18 
and may represent an area where improvements could 
be made to the efficiency of running paediatric clinical 
trials. An increase in level of nurse prescribing would 
seem to represent a sensible way to optimise the skills and 
expertise of all health professionals working in increas-
ingly stretched healthcare systems.19 It is unclear whether 
or not the observed increased research nurse prescribing 
rates in countries such as Norway and Switzerland reflects 
a real difference, possibly related to more accessible 
training and accreditation in these countries, as the 
numbers of respondents from the majority of countries 
was small. Similarly, differences highlighted between 
countries in the percentages of research nurses actively 
involved in taking patient consent and the administra-
tion of IMPs should be interpreted with caution.
conclusIon
In summary, the study provides a useful overview of 
the current training status of research nurses working 
in paediatric medicine, highlighting potential training 
needs and summarising the roles and activities of 
research nurses across Europe. As higher percentages 
of respondents received self-funded training and/
or were not satisfied with the level of training in some 
European countries, this would suggest that different 
training opportunities and historical working cultures 
may currently exist. While the level of training and 
general satisfaction levels expressed by research nurses 
is encouraging, approximately two-thirds of respondents 
felt that they would benefit from additional training, with 
commonly requested areas for further training high-
lighted. Increased availability and provision of research 
nurse training in these areas may facilitate an increased 
efficiency in the running of clinical trials in a paediatric 
setting. Sharing of the information generated in the 
current study through Enpr-EMA and national research 
nurse networks will be strongly encouraged, with a view 
to supporting, facilitating and developing new research 
training programme for paediatric research nurses 
across Europe. In this respect, Enpr-EMA should look to 
enhance the design of the European paediatric research 
nurse core curriculum, together with relevant European 
Nursing Associations, which could be then adopted 
across EU countries. Increased collaboration and discus-
sion between key stakeholders will help to harmonise 
approaches to training and standardise the way that 
paediatric clinical trials are conducted across Europe, 
promoting improved ethical and clinical standards and 
the generation of robust results from clinical trials.
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